Treatment with Dulaglutide has been found to reduce binge eating frequency, body weight, body mass index, body fat percentage, and glycated hemoglobin in diabetic patients with binge eating disorder
This is particularly important for patients experiencing gastrointestinal side effects from metformin, which can lead to dehydration and potentially worsen vision symptoms
However, no research exists to show what benefits administering a sermorelin-ipamorelin blend may offer or whether, as these two peptides work along different pathways, a blend increases GH secretion more effectively
Many people know GLP-1 medications for their role in weight management, but research now shows that these therapies may also support blood sugar control, cardiovascular health, inflammation reduction, longevity, cognition, and metabolic health